The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Blood Plasma Fractionation Market Research Report 2025

Global Human Blood Plasma Fractionation Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1674090

No of Pages : 92

Ask Your Query
Synopsis
Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Blood Plasma Fractionation

The global Human Blood Plasma Fractionation market was valued at US$ 30330 million in 2023 and is anticipated to reach US$ 50750 million by 2030, witnessing a CAGR of 7.6% during the forecast period 2024-2030.

The Blood Plasma Fractionation Product market is driven by the growing demand for plasma-derived therapies and the increasing prevalence of chronic and rare diseases. Plasma fractionation involves separating and purifying plasma components to produce therapies such as immunoglobulins, clotting factors, and albumin. The rise in awareness about the therapeutic benefits of plasma-derived products and the need for specialized treatments contribute to market growth as patients and healthcare providers seek effective solutions. Moreover, advancements in fractionation technologies, including improved product yields and safety profiles, align with better patient outcomes. However, the market also faces challenges, including ensuring a stable supply of plasma donors and addressing regulatory complexities related to plasma collection and product manufacturing. Additionally, competition from alternative therapies and addressing concerns about supply chain disruptions can pose obstacles for manufacturers. To succeed, companies must focus on research and development to offer innovative and safe plasma fractionation products, collaborate with healthcare professionals for therapeutic insights, and address the challenges to meet the increasing demand for specialized and life-saving plasma-derived therapies.

This report aims to provide a comprehensive presentation of the global market for Human Blood Plasma Fractionation, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Blood Plasma Fractionation.

Report Scope

The Human Blood Plasma Fractionation market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Blood Plasma Fractionation market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Blood Plasma Fractionation companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Takeda

CSL

Grifols

Octapharma

Kedrion

LFB Group

Biotest

BPL

RAAS

CBPO

Hualan Bio

Tiantan Bio

Shuanglin Bio

Boya Bio

Yuanda Shuyang

Weiguang Bio

Nanyue Bio

KM Biologics

Segment by Type

Immune Globulin

Coagulation Factor

Albumin

Others

Segment by Application

Hospital

Retail Pharmacy

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Blood Plasma Fractionation companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Human Blood Plasma Fractionation Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Immune Globulin

1.2.3 Coagulation Factor

1.2.4 Albumin

1.2.5 Others

1.3 Market by Application

1.3.1 Global Human Blood Plasma Fractionation Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Retail Pharmacy

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Human Blood Plasma Fractionation Market Perspective (2019-2030)

2.2 Human Blood Plasma Fractionation Growth Trends by Region

2.2.1 Global Human Blood Plasma Fractionation Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Human Blood Plasma Fractionation Historic Market Size by Region (2019-2024)

2.2.3 Human Blood Plasma Fractionation Forecasted Market Size by Region (2025-2030)

2.3 Human Blood Plasma Fractionation Market Dynamics

2.3.1 Human Blood Plasma Fractionation Industry Trends

2.3.2 Human Blood Plasma Fractionation Market Drivers

2.3.3 Human Blood Plasma Fractionation Market Challenges

2.3.4 Human Blood Plasma Fractionation Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Human Blood Plasma Fractionation Players by Revenue

3.1.1 Global Top Human Blood Plasma Fractionation Players by Revenue (2019-2024)

3.1.2 Global Human Blood Plasma Fractionation Revenue Market Share by Players (2019-2024)

3.2 Global Human Blood Plasma Fractionation Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Human Blood Plasma Fractionation Revenue

3.4 Global Human Blood Plasma Fractionation Market Concentration Ratio

3.4.1 Global Human Blood Plasma Fractionation Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Human Blood Plasma Fractionation Revenue in 2023

3.5 Human Blood Plasma Fractionation Key Players Head office and Area Served

3.6 Key Players Human Blood Plasma Fractionation Product Solution and Service

3.7 Date of Enter into Human Blood Plasma Fractionation Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Human Blood Plasma Fractionation Breakdown Data by Type

4.1 Global Human Blood Plasma Fractionation Historic Market Size by Type (2019-2024)

4.2 Global Human Blood Plasma Fractionation Forecasted Market Size by Type (2025-2030)

5 Human Blood Plasma Fractionation Breakdown Data by Application

5.1 Global Human Blood Plasma Fractionation Historic Market Size by Application (2019-2024)

5.2 Global Human Blood Plasma Fractionation Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Human Blood Plasma Fractionation Market Size (2019-2030)

6.2 North America Human Blood Plasma Fractionation Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Human Blood Plasma Fractionation Market Size by Country (2019-2024)

6.4 North America Human Blood Plasma Fractionation Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Human Blood Plasma Fractionation Market Size (2019-2030)

7.2 Europe Human Blood Plasma Fractionation Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Human Blood Plasma Fractionation Market Size by Country (2019-2024)

7.4 Europe Human Blood Plasma Fractionation Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Human Blood Plasma Fractionation Market Size (2019-2030)

8.2 Asia-Pacific Human Blood Plasma Fractionation Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Human Blood Plasma Fractionation Market Size by Region (2019-2024)

8.4 Asia-Pacific Human Blood Plasma Fractionation Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Human Blood Plasma Fractionation Market Size (2019-2030)

9.2 Latin America Human Blood Plasma Fractionation Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Human Blood Plasma Fractionation Market Size by Country (2019-2024)

9.4 Latin America Human Blood Plasma Fractionation Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Human Blood Plasma Fractionation Market Size (2019-2030)

10.2 Middle East & Africa Human Blood Plasma Fractionation Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2019-2024)

10.4 Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Detail

11.1.2 Takeda Business Overview

11.1.3 Takeda Human Blood Plasma Fractionation Introduction

11.1.4 Takeda Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.1.5 Takeda Recent Development

11.2 CSL

11.2.1 CSL Company Detail

11.2.2 CSL Business Overview

11.2.3 CSL Human Blood Plasma Fractionation Introduction

11.2.4 CSL Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.2.5 CSL Recent Development

11.3 Grifols

11.3.1 Grifols Company Detail

11.3.2 Grifols Business Overview

11.3.3 Grifols Human Blood Plasma Fractionation Introduction

11.3.4 Grifols Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.3.5 Grifols Recent Development

11.4 Octapharma

11.4.1 Octapharma Company Detail

11.4.2 Octapharma Business Overview

11.4.3 Octapharma Human Blood Plasma Fractionation Introduction

11.4.4 Octapharma Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.4.5 Octapharma Recent Development

11.5 Kedrion

11.5.1 Kedrion Company Detail

11.5.2 Kedrion Business Overview

11.5.3 Kedrion Human Blood Plasma Fractionation Introduction

11.5.4 Kedrion Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.5.5 Kedrion Recent Development

11.6 LFB Group

11.6.1 LFB Group Company Detail

11.6.2 LFB Group Business Overview

11.6.3 LFB Group Human Blood Plasma Fractionation Introduction

11.6.4 LFB Group Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.6.5 LFB Group Recent Development

11.7 Biotest

11.7.1 Biotest Company Detail

11.7.2 Biotest Business Overview

11.7.3 Biotest Human Blood Plasma Fractionation Introduction

11.7.4 Biotest Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.7.5 Biotest Recent Development

11.8 BPL

11.8.1 BPL Company Detail

11.8.2 BPL Business Overview

11.8.3 BPL Human Blood Plasma Fractionation Introduction

11.8.4 BPL Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.8.5 BPL Recent Development

11.9 RAAS

11.9.1 RAAS Company Detail

11.9.2 RAAS Business Overview

11.9.3 RAAS Human Blood Plasma Fractionation Introduction

11.9.4 RAAS Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.9.5 RAAS Recent Development

11.10 CBPO

11.10.1 CBPO Company Detail

11.10.2 CBPO Business Overview

11.10.3 CBPO Human Blood Plasma Fractionation Introduction

11.10.4 CBPO Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.10.5 CBPO Recent Development

11.11 Hualan Bio

11.11.1 Hualan Bio Company Detail

11.11.2 Hualan Bio Business Overview

11.11.3 Hualan Bio Human Blood Plasma Fractionation Introduction

11.11.4 Hualan Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.11.5 Hualan Bio Recent Development

11.12 Tiantan Bio

11.12.1 Tiantan Bio Company Detail

11.12.2 Tiantan Bio Business Overview

11.12.3 Tiantan Bio Human Blood Plasma Fractionation Introduction

11.12.4 Tiantan Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.12.5 Tiantan Bio Recent Development

11.13 Shuanglin Bio

11.13.1 Shuanglin Bio Company Detail

11.13.2 Shuanglin Bio Business Overview

11.13.3 Shuanglin Bio Human Blood Plasma Fractionation Introduction

11.13.4 Shuanglin Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.13.5 Shuanglin Bio Recent Development

11.14 Boya Bio

11.14.1 Boya Bio Company Detail

11.14.2 Boya Bio Business Overview

11.14.3 Boya Bio Human Blood Plasma Fractionation Introduction

11.14.4 Boya Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.14.5 Boya Bio Recent Development

11.15 Yuanda Shuyang

11.15.1 Yuanda Shuyang Company Detail

11.15.2 Yuanda Shuyang Business Overview

11.15.3 Yuanda Shuyang Human Blood Plasma Fractionation Introduction

11.15.4 Yuanda Shuyang Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.15.5 Yuanda Shuyang Recent Development

11.16 Weiguang Bio

11.16.1 Weiguang Bio Company Detail

11.16.2 Weiguang Bio Business Overview

11.16.3 Weiguang Bio Human Blood Plasma Fractionation Introduction

11.16.4 Weiguang Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.16.5 Weiguang Bio Recent Development

11.17 Nanyue Bio

11.17.1 Nanyue Bio Company Detail

11.17.2 Nanyue Bio Business Overview

11.17.3 Nanyue Bio Human Blood Plasma Fractionation Introduction

11.17.4 Nanyue Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.17.5 Nanyue Bio Recent Development

11.18 KM Biologics

11.18.1 KM Biologics Company Detail

11.18.2 KM Biologics Business Overview

11.18.3 KM Biologics Human Blood Plasma Fractionation Introduction

11.18.4 KM Biologics Revenue in Human Blood Plasma Fractionation Business (2019-2024)

11.18.5 KM Biologics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details
List of Tables
List of Tables

Table 1. Global Human Blood Plasma Fractionation Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Immune Globulin

Table 3. Key Players of Coagulation Factor

Table 4. Key Players of Albumin

Table 5. Key Players of Others

Table 6. Global Human Blood Plasma Fractionation Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Human Blood Plasma Fractionation Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Human Blood Plasma Fractionation Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Human Blood Plasma Fractionation Market Share by Region (2019-2024)

Table 10. Global Human Blood Plasma Fractionation Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Human Blood Plasma Fractionation Market Share by Region (2025-2030)

Table 12. Human Blood Plasma Fractionation Market Trends

Table 13. Human Blood Plasma Fractionation Market Drivers

Table 14. Human Blood Plasma Fractionation Market Challenges

Table 15. Human Blood Plasma Fractionation Market Restraints

Table 16. Global Human Blood Plasma Fractionation Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Human Blood Plasma Fractionation Market Share by Players (2019-2024)

Table 18. Global Top Human Blood Plasma Fractionation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Plasma Fractionation as of 2023)

Table 19. Ranking of Global Top Human Blood Plasma Fractionation Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Human Blood Plasma Fractionation Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Human Blood Plasma Fractionation Product Solution and Service

Table 23. Date of Enter into Human Blood Plasma Fractionation Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Human Blood Plasma Fractionation Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Human Blood Plasma Fractionation Revenue Market Share by Type (2019-2024)

Table 27. Global Human Blood Plasma Fractionation Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Human Blood Plasma Fractionation Revenue Market Share by Type (2025-2030)

Table 29. Global Human Blood Plasma Fractionation Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Human Blood Plasma Fractionation Revenue Market Share by Application (2019-2024)

Table 31. Global Human Blood Plasma Fractionation Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Human Blood Plasma Fractionation Revenue Market Share by Application (2025-2030)

Table 33. North America Human Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Human Blood Plasma Fractionation Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Human Blood Plasma Fractionation Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Human Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Human Blood Plasma Fractionation Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Human Blood Plasma Fractionation Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Human Blood Plasma Fractionation Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Human Blood Plasma Fractionation Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Human Blood Plasma Fractionation Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Human Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Human Blood Plasma Fractionation Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Human Blood Plasma Fractionation Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Human Blood Plasma Fractionation Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Human Blood Plasma Fractionation Market Size by Country (2025-2030) & (US$ Million)

Table 48. Takeda Company Detail

Table 49. Takeda Business Overview

Table 50. Takeda Human Blood Plasma Fractionation Product

Table 51. Takeda Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 52. Takeda Recent Development

Table 53. CSL Company Detail

Table 54. CSL Business Overview

Table 55. CSL Human Blood Plasma Fractionation Product

Table 56. CSL Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 57. CSL Recent Development

Table 58. Grifols Company Detail

Table 59. Grifols Business Overview

Table 60. Grifols Human Blood Plasma Fractionation Product

Table 61. Grifols Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 62. Grifols Recent Development

Table 63. Octapharma Company Detail

Table 64. Octapharma Business Overview

Table 65. Octapharma Human Blood Plasma Fractionation Product

Table 66. Octapharma Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 67. Octapharma Recent Development

Table 68. Kedrion Company Detail

Table 69. Kedrion Business Overview

Table 70. Kedrion Human Blood Plasma Fractionation Product

Table 71. Kedrion Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 72. Kedrion Recent Development

Table 73. LFB Group Company Detail

Table 74. LFB Group Business Overview

Table 75. LFB Group Human Blood Plasma Fractionation Product

Table 76. LFB Group Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 77. LFB Group Recent Development

Table 78. Biotest Company Detail

Table 79. Biotest Business Overview

Table 80. Biotest Human Blood Plasma Fractionation Product

Table 81. Biotest Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 82. Biotest Recent Development

Table 83. BPL Company Detail

Table 84. BPL Business Overview

Table 85. BPL Human Blood Plasma Fractionation Product

Table 86. BPL Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 87. BPL Recent Development

Table 88. RAAS Company Detail

Table 89. RAAS Business Overview

Table 90. RAAS Human Blood Plasma Fractionation Product

Table 91. RAAS Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 92. RAAS Recent Development

Table 93. CBPO Company Detail

Table 94. CBPO Business Overview

Table 95. CBPO Human Blood Plasma Fractionation Product

Table 96. CBPO Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 97. CBPO Recent Development

Table 98. Hualan Bio Company Detail

Table 99. Hualan Bio Business Overview

Table 100. Hualan Bio Human Blood Plasma Fractionation Product

Table 101. Hualan Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 102. Hualan Bio Recent Development

Table 103. Tiantan Bio Company Detail

Table 104. Tiantan Bio Business Overview

Table 105. Tiantan Bio Human Blood Plasma Fractionation Product

Table 106. Tiantan Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 107. Tiantan Bio Recent Development

Table 108. Shuanglin Bio Company Detail

Table 109. Shuanglin Bio Business Overview

Table 110. Shuanglin Bio Human Blood Plasma Fractionation Product

Table 111. Shuanglin Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 112. Shuanglin Bio Recent Development

Table 113. Boya Bio Company Detail

Table 114. Boya Bio Business Overview

Table 115. Boya Bio Human Blood Plasma Fractionation Product

Table 116. Boya Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 117. Boya Bio Recent Development

Table 118. Yuanda Shuyang Company Detail

Table 119. Yuanda Shuyang Business Overview

Table 120. Yuanda Shuyang Human Blood Plasma Fractionation Product

Table 121. Yuanda Shuyang Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 122. Yuanda Shuyang Recent Development

Table 123. Weiguang Bio Company Detail

Table 124. Weiguang Bio Business Overview

Table 125. Weiguang Bio Human Blood Plasma Fractionation Product

Table 126. Weiguang Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 127. Weiguang Bio Recent Development

Table 128. Nanyue Bio Company Detail

Table 129. Nanyue Bio Business Overview

Table 130. Nanyue Bio Human Blood Plasma Fractionation Product

Table 131. Nanyue Bio Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 132. Nanyue Bio Recent Development

Table 133. KM Biologics Company Detail

Table 134. KM Biologics Business Overview

Table 135. KM Biologics Human Blood Plasma Fractionation Product

Table 136. KM Biologics Revenue in Human Blood Plasma Fractionation Business (2019-2024) & (US$ Million)

Table 137. KM Biologics Recent Development

Table 138. Research Programs/Design for This Report

Table 139. Key Data Information from Secondary Sources

Table 140. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Human Blood Plasma Fractionation Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Human Blood Plasma Fractionation Market Share by Type: 2023 VS 2030

Figure 3. Immune Globulin Features

Figure 4. Coagulation Factor Features

Figure 5. Albumin Features

Figure 6. Others Features

Figure 7. Global Human Blood Plasma Fractionation Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Human Blood Plasma Fractionation Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Retail Pharmacy Case Studies

Figure 11. Others Case Studies

Figure 12. Human Blood Plasma Fractionation Report Years Considered

Figure 13. Global Human Blood Plasma Fractionation Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Human Blood Plasma Fractionation Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Human Blood Plasma Fractionation Market Share by Region: 2023 VS 2030

Figure 16. Global Human Blood Plasma Fractionation Market Share by Players in 2023

Figure 17. Global Top Human Blood Plasma Fractionation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Blood Plasma Fractionation as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Human Blood Plasma Fractionation Revenue in 2023

Figure 19. North America Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Human Blood Plasma Fractionation Market Share by Country (2019-2030)

Figure 21. United States Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Human Blood Plasma Fractionation Market Share by Country (2019-2030)

Figure 25. Germany Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Human Blood Plasma Fractionation Market Share by Region (2019-2030)

Figure 33. China Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Human Blood Plasma Fractionation Market Share by Country (2019-2030)

Figure 41. Mexico Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Human Blood Plasma Fractionation Market Share by Country (2019-2030)

Figure 45. Turkey Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Human Blood Plasma Fractionation Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Takeda Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 48. CSL Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 49. Grifols Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 50. Octapharma Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 51. Kedrion Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 52. LFB Group Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 53. Biotest Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 54. BPL Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 55. RAAS Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 56. CBPO Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 57. Hualan Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 58. Tiantan Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 59. Shuanglin Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 60. Boya Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 61. Yuanda Shuyang Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 62. Weiguang Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 63. Nanyue Bio Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 64. KM Biologics Revenue Growth Rate in Human Blood Plasma Fractionation Business (2019-2024)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock